Name | 3-[18-(2-carboxylatoethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoate,hydron,tin(4+),dichloride |
---|---|
Synonyms |
tin mesoporphyrin IX dichloride
Tin mesoporphyrin Sn Mesoporphyrin Stannsoporfin SNMPP Stanate |
Description | Tin(IV) mesoporphyrin IX dichloride (Stannsoporfin) is a heme oxygenase (HO) inhibitor being developed for the prevention of hyperbilirubinemia in infants at risk of developing jaundice, extracted from patent WO2011103196A1[1]. |
---|---|
Related Catalog | |
Target |
HO[1] |
References |
Boiling Point | 1096.1ºC at 760mmHg |
---|---|
Molecular Formula | C34H36Cl2N4O4Sn |
Molecular Weight | 754.28100 |
Flash Point | 616.7ºC |
Exact Mass | 754.11400 |
PSA | 130.76000 |
LogP | 1.88710 |
Vapour Pressure | 0mmHg at 25°C |
~95% 106344-20-1 |
Literature: BOUCHER, Christopher P.; ROE, David Patent: US2012/253033 A1, 2012 ; Location in patent: Page/Page column 6 ; |
~% 106344-20-1 |
Literature: US2012/253033 A1, ; Page/Page column 8-9 ; |
Precursor 2 | |
---|---|
DownStream 0 |